← All companies
MCLE
Medicale Corp.
$0.00
-0.02 -99.20%
Key statistics
from XBRL data in SEC filingsMarket cap
$1.18K
Revenue (TTM)
$0.00
Net income (TTM)
-$29.8K
EPS (TTM)
$-0.01
P/E ratio
—
Dividend yield
—
Free cash flow
—
Cash
$0.00
Total assets
$0.00
Gross margin
—
52-week range
$0.00 – $6.35
Recent SEC filings
40 most recentAnnual, quarterly & current reports
10-Q
Quarter ended 2025-12-31
Feb 17, 2026
10-K
Fiscal year ended 2025-09-30
Jan 12, 2026
10-Q
Quarter ended 2025-06-30
Aug 15, 2025
10-Q
Quarter ended 2025-03-31
May 15, 2025
10-Q/A
Quarter ended 2024-12-31
Feb 20, 2025
10-Q
Quarter ended 2024-12-31
Feb 18, 2025
10-K
Fiscal year ended 2024-09-30
Jan 14, 2025
8-K
Changed accountants
Dec 31, 2024
10-Q
Quarter ended 2024-06-30
Aug 15, 2024
10-Q
Quarter ended 2024-03-31
May 14, 2024
10-Q
Quarter ended 2023-12-31
Feb 15, 2024
10-K
Fiscal year ended 2023-09-30
Jan 2, 2024
8-K
Changed accountants
Dec 11, 2023
8-K
Regulation FD disclosure
Oct 30, 2023
10-Q/A
Quarter ended 2023-06-30
Aug 21, 2023
10-Q
Quarter ended 2023-06-30
Aug 14, 2023
10-Q
Quarter ended 2023-03-31
May 22, 2023
8-K
Changed accountants
May 9, 2023
10-Q
Quarter ended 2022-12-31
Feb 14, 2023
8-K
Change in control; Director or officer change; Other events
Jan 9, 2023
10-K
Fiscal year ended 2022-09-30
Dec 2, 2022
10-Q
Quarter ended 2022-06-30
Aug 4, 2022
10-Q
Quarter ended 2022-03-31
Apr 29, 2022
10-Q
Quarter ended 2021-12-31
Jan 26, 2022
10-K
Fiscal year ended 2021-09-30
Dec 15, 2021
10-Q
Quarter ended 2021-06-30
Aug 16, 2021
10-Q
Quarter ended 2021-03-31
May 12, 2021
10-Q
Quarter ended 2020-12-31
Feb 1, 2021
Other filings
NT 10-K
EXTENSION
Dec 30, 2025
NT 10-Q
NOTIFICATION OF LATE FILING
Aug 15, 2025
NT 10-Q
EXTENSION
Feb 14, 2025
NT 10-K
EXTENSION
Dec 30, 2024
NT 10-Q
10-Q EXTENSION
Aug 15, 2024
NT 10-Q
EXTENSION
Feb 15, 2024
NT 10-K
FORM 12B-25
Jan 2, 2024
NT 10-Q
May 16, 2023
EFFECT
Item S-1; Item 2021-01-13; Item 12:00:00
Jan 13, 2021
CORRESP
Jan 11, 2021
CORRESP
Jan 5, 2021
S-1/A
AMENDMENT NO. 4
Jan 5, 2021